COMMUNIQUÉS West-GlobeNewswire
-
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
26/07/2026 -
SugarReset Official Lunch2026 Natural Blood Sugar Support Drops for Healthy Glucose Levels Available in USA, Sugar Reset Highlights Ingredient, Supplement Facts
26/07/2026 -
BloodPril Launch 2026 Natural Blood Pressure Support Capsule Highlights Ingredients, Supplement Facts Available Blood Pril in the USA
26/07/2026 -
CogniHoney Opens Up Its 2026 Formula: What the Four-Ingredient Label Shows About Baobab Fiber and Spermidine
26/07/2026 -
ARCPOINT PROVIDES LEADERSHIP UPDATE
25/07/2026 -
Nordic Naturals Releases Expert Insights on Why Omega-3s Should Be on Back-to-School Checklists
24/07/2026 -
HorseFil Official Launch 2026 Effective Men's Energy and Vitality Gummies Highlights Ingredient, Supplement Facts Available in USA
24/07/2026 -
Affidea accélère sa croissance au Royaume-Uni en signant un partenariat stratégique avec LIPS Healthcare
24/07/2026 -
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
24/07/2026 -
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
24/07/2026 -
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/07/2026 -
LifeMD to Report Second Quarter 2026 Financial Results on August 5
24/07/2026 -
Sienna Announces Confirmation of Morningstar DBRS Credit Rating
24/07/2026 -
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
24/07/2026 -
Maxim Hair Restoration Named Top US Hair Restoration Brand 2026, Reinforcing Its Position Among the Best Hair Restoration Clinics in America
24/07/2026 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24/07/2026 -
ColestZen Publishes Ingredient Facts for Its 18-Ingredient Supplement Formula: Serving Directions and Safety Information for 2026
24/07/2026 -
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
24/07/2026 -
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
24/07/2026
Pages